Abbott’s device sales drive profit beat, but shares fall as forecast disappoints
Abbott Laboratories beat Wall Street estimates for quarterly profit on Wednesday on robust sales of its medical devices, but the company’s stock fell 3% in morning trading, signaling disappointment over its annual forecast.